Literature DB >> 15577588

Clinical validation of fully 3-D versus 2.5-D RAMLA reconstruction on the Philips-ADAC CPET PET scanner.

Stephen Chiang1, Chris Cardi, Samuel Matej, Hongming Zhuang, Andrew Newberg, Abass Alavi, Joel S Karp.   

Abstract

INTRODUCTION: Fully three-dimensional (3-D) reconstruction algorithms have the potential to better utilize PET data acquired in true 3-D acquisition modes, as compared to 2-D approaches involving data reduction through rebinning procedures followed by a 2-D or 2.5-D reconstruction. Our previous studies, involving simulated and real phantom data from PET scanners working purely in 3-D acquisition mode, showed that the fully 3-D reconstruction approaches bring appreciable improvement on physical measures and visual image quality as well. Reconstruction procedures utilized in those studies were based upon the row action maximum likelihood algorithm (RAMLA) implemented on our clinical scanners. The purpose of this study was to investigate if the fully 3-D RAMLA reconstruction software brings an appreciable improvement in clinical image quality and reader confidence.
MATERIALS AND METHODS: Ninety patient scans acquired on the Philips CPET scanner at our institution were reconstructed using 2.5-D RAMLA and 3-D RAMLA with differing reconstruction parameters. These scans were blindly presented to four experienced PET scan readers who graded various aspects of image quality.
RESULTS: Our study concluded that 3-D RAMLA on the CPET scanner reduces artifacts and image noise and improves clinical confidence in interpreting PET images.
CONCLUSION: This study led to the routine use of 3-D RAMLA reconstruction on the CPET scanner at our institution.

Entities:  

Mesh:

Year:  2004        PMID: 15577588     DOI: 10.1097/00006231-200411000-00006

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  5 in total

1.  Usefulness of automatic quantification of immunochemical staining on whole tumor sections for correlation with oncological small animal PET studies: an example with cell proliferation, glucose transporter 1 and FDG.

Authors:  Nicolas Aide; Alexandre Labiche; Paulette Herlin; Maria Paciencia; Laurent Poulain; Soizic Dutoit; Françoise Montravers; Pascal Gauduchon; Jacques Chasle
Journal:  Mol Imaging Biol       Date:  2008-06-10       Impact factor: 3.488

2.  Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner.

Authors:  D Visvikis; D Griffiths; D C Costa; J Bomanji; P J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-22       Impact factor: 9.236

3.  Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.

Authors:  Donna S Dorow; Carleen Cullinane; Nelly Conus; Peter Roselt; David Binns; Timothy J McCarthy; Grant A McArthur; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

4.  Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease.

Authors:  Nicolas Aide; Laurent Poulain; Mélanie Briand; Soizic Dutoit; Stéphane Allouche; Alexandre Labiche; Aurélie Ngo-Van Do; Valérie Nataf; Alain Batalla; Pascal Gauduchon; Jean-noël Talbot; Françoise Montravers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-03       Impact factor: 9.236

5.  Comparison of three image segmentation techniques for target volume delineation in positron emission tomography.

Authors:  Laura A Drever; Wilson Roa; Alexander McEwan; Don Robinson
Journal:  J Appl Clin Med Phys       Date:  2007-03-09       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.